Whittle et al. J. Med. Microbiol. 46:1029-1038, Dec. 1997.* |
Sasaki et al. Journal of Virology. 72(6): 4931-9, Jun. 1998.* |
Natuk et al. Dev Biol Standard. 82: 71-7, 1994.* |
Robinson, HL. Vaccine. 15(8): 785-787, Jun. 1997.* |
Staats et al. Cur Opin Immunology. 6: 572-583, Aug. 1994.* |
McCluskie et al. Molecular Medicine. 287-300, May 1999.* |
Barnett et al. J Neuroimmunology. 64: 163-173, Dec. 1997.* |
J. J. Kim, “Development of a Multicomponent Candidate Vaccine for HIV-1,” Vaccine, 15 (8):879 (Jun. 1997). |
S.W. Barnett et al., “Vaccination with HIV-1 gp 120 DNA Induces Immune Responses that are Boosted by a Recombinant gp120 Protein Subunit,” Vaccine, 15(80):869-873 (Jun. 1997). |
N.L. Letvin et al., “Potent, Protective anti-HIV Immune Responses Generated by Binodal HIV Envelope DNA Plus Protein Vaccination,” Proc. Natl. Acad. Sci., USA, 94:9378-9383 (Aug. 1997). |
R.A. Gramzinski et al., “Immune Response to a Hepatitis B DNA Vaccine in Aotus Monkeys: A Comparison of Vaccine Formulation, Route, and Method of Administration,” Molecular Med., 4:109-118 (Feb. 1998). |
Z. Xiang and H. Ertl, “Induction of Mucosal Immunity with a Replication-Defective Adenoviral Recombinant,” Vaccine, 17:2003-2008 (Apr. 9, 1999). |
Z. Xiang et al., “Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant,” J. Immunol., 6716 (Jun. 1, 1999). |
J. Schneider et al., “Enhanced Immunogenicity for CD9+ T Cell Induction and Complete Protective Efficacy of Malaria DNA Vaccination by Boosting with Modified Vaccinia Virus Ankara,” Nature Med., 4:397 (Apr. 1998). |
M. Sedeguh et al., “Boosting with Recombinant Vaccinia Increases Immunogenicity and Protective Efficacy of Malaria DNA Vaccine,” Proc. Natl. Acad. Sci., USA, 95:7648 (Jun. 1998). |
Database Medline on PubMed, The Wistar Institute, (Philadelphia, PA, USA), PMID: 10217600, UI: 99231952, Xiang et al., “Induction of Mucosal Immunity with a Replication-Defective Adenoviral Recombinant”, Abstract, Vaccine (Apr. 9, 1999). |
Database Medline on PubMed, The Wistar Institute, (Philadelphia, PA, USA), PMID: 10352290, UI:99282958, Xiang et al., “Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant”, Abstract, J. Immunol. (Jun. 1, 1999). |
Staats et al., “Mucosal Immunity to Infection with Implications for Vaccine Development”, Curr. Opin. Immunol., 6:572-583 (Aug. 1994). |
Holmgren et al., “Mucosal Immunity: Implications for Vaccine Development,” Immunobiol., 184:157-179 (Feb. 1992). |
Hopkins et al., “A Recombinant Salmonella typhimurium Vaccine induces Local Immunity by Four Different Routes of Immunization,” Infect. Immun., 63:3279-3286 (Sep. 1995). |
Wu and Russell, “Induction of Mucosal Immunity by Intranasal Application of a Streptococcal Surface Protein Antigen with the Cholera Toxin B Subunit,” Infect. Immun., 61:314-322 (Jan. 1993). |
Staats et al., “Systemic and Vaginal Antibody Responses After Intranasal Immunization with the HIV-1 C4/V3 Peptide T1SP10 MN(A),” J. Immunol., 157:462-472 (Jul. 1, 1996). |
Gallichan and Rosenthal, “Specific Secretory Immune Responses in the Female Genital Tract Following Intranasal Immunization with a Recombinant Adenovirus Expressing Glycoprotein V of Herpes Simplex Virus,” Vaccine, 13:1589-1595 (Nov. 1995). |
Lehner et al., “Protective Mucosal Immunity Elicited by Targeted Iliac Lymph Node Immunization with a Subunit SIV Envelope and Core Vaccine Macaques,” Nature Med., 2:767-775 (Jul. 1996). |
Yang et al., “Cellular and Humoral Immune Responses to Viral Antigens Create Barriers to Lung-Directed Gene Therapy with Recombinant Adenoviruses,” J. Virol., 69:2004-2015 (Apr. 1995). |
Yang et al., “Immune Responses to Viral Antigens Versus Transgene Product in the Elimination of Recombinant Adenovirus-Infected Heptaocytes in Vivo,” Gene Therapy, 3:137-144 (1995). |
Kuklin et al., “Induction of Mucosal Immunity Against Herpes Simplex Virus by Plasmid DNA Immunization,” J. Virol., 71:3138-3145 (Apr. 1997). |
Xu-Amano et al., “Helper T Cell Subsets for Immunoglobulin A Response: Oral Immunization with Tetanus Toxoid and Cholera toxin as Adjuvant Selectively Induces Th2 Cells in Mucosa Associated Tissues,” J. Exp. Med., 178:1309-1320 (Oct. 1993). |
Fujihashi, “γ/βCell-Deficient Mice have Impaired Mucosal Immunoglobulin A Responses,” J. Exp. Med., 183:1929-1935 (Apr. 1996). |